14-73173655-T-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000021.4(PSEN1):c.428T>C(p.Ile143Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I143F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000021.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSEN1 | NM_000021.4 | c.428T>C | p.Ile143Thr | missense_variant | Exon 5 of 12 | ENST00000324501.10 | NP_000012.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
- -
- -
Pick disease;C0338451:Frontotemporal dementia;C1843013:Alzheimer disease 3;C3151038:Acne inversa, familial, 3 Pathogenic:1
Experimental studies have shown that this missense change affects PSEN1 function (PMID: 19276550, 19276551, 22508690, 27930341). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PSEN1 protein function. ClinVar contains an entry for this variant (Variation ID: 98026). This missense change has been observed in individuals with early-onset Alzheimer's disease (PMID: 8634711, 17968601, 20628413, 24773620, 28350801, 30090657, 30528841). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 143 of the PSEN1 protein (p.Ile143Thr). -
Alzheimer disease 3 Pathogenic:1
This sequence change in PSEN1 is predicted to replace isoleucine with threonine at codon 143, p.(Ile143Thr). The isoleucine residue is highly conserved (100 vertebrates, UCSC), and is located in Transmembrane-II domain. There is a moderate physicochemical difference between isoleucine and threonine. This variant is absent from gnomAD v2.1 and v3.1. This variant has been reported in various probands/families internationally with early-onset Alzheimer's disease (EOAD) and segregates with disease in multiple families (PMID: 8634711, 11568920, 17968601, 20628413, 30090657). The variant deregulates neurite growth in functional assays and significantly reduces brain glucosylceramide and gangliosides in a knock-in mouse model, similarly to human EOAD patients (PMID: 11157069, 22508690). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (5/5 algorithms). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PP1_Strong, PS3_Moderate, PS4_Moderate, PM2_Supporting, PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at